2.40 USD
↘ 0.11 (4.38%)AT CLOSE (11:59 AM EDT)
Moleculin Biotech, Inc.
MBRXNASDAQ • USD
2.48
↗ 0.08 (3.13%)
POST MARKET (AS OF 07:48 PM EDT)
Post Market
AS OF 07:48 PM EDT
2.48
↗ 0.08 (3.13%)
Market: CLOSED
Open?$2.57
High?$2.60
Low?$2.37
Prev. Close?$2.51
Volume?225.9K
Avg. Volume?241.2K
VWAP?$2.50
Rel. Volume?0.94x
Bid / Ask
Bid?$2.36 × 2.0K
Ask?$2.48 × 100
Spread?$0.12
Midpoint?$2.42
Valuation & Ratios
Market Cap?12.8M
Shares Out?5.3M
Float?4.9M
Float %?92.4%
P/E Ratio?N/A
P/B Ratio?0.84
EPS?-$6.03
Dividend?0.00%
Ex-Dividend?N/A
MBRX is currently priced at $2.40. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.
Themes
Employees
17
Market Cap
12.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2016-06-02
Address
5300 MEMORIAL DRIVE
HOUSTON, TX 77007
Phone: 713-300-5160
HOUSTON, TX 77007
Phone: 713-300-5160
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?36
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.84Distress
Confidence?51%Low
Short InterestHigh
Short % of Float?10.70%High
Short Interest?527.8K
Days to Cover?2.1
Free Float4.9M
Avg Daily Volume249.1K
Settlement Date2026-05-15
Financial Health
Current Ratio?1.38Adequate
Quick Ratio?1.38Adequate
Cash Ratio?1.30Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.84CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-212.1%WEAK▾
S&P3
ROA?-137.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$2.5M
Fundamentals ratios updated end of day